Beijing Strong Biotechnologies Inc (SHE:300406) — Market Cap & Net Worth

$967.77 Million USD  · CN¥6.61 Billion CNY  · Rank #9080

Market Cap & Net Worth: Beijing Strong Biotechnologies Inc (300406)

Beijing Strong Biotechnologies Inc (SHE:300406) has a market capitalization of $967.77 Million (CN¥6.61 Billion) as of September 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #9080 globally and #2232 in its home market, demonstrating a -3.75% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Beijing Strong Biotechnologies Inc's stock price CN¥11.28 by its total outstanding shares 586308628 (586.31 Million). Also see 300406 current and non-current assets for a full breakdown of the balance sheet.

Beijing Strong Biotechnologies Inc Market Cap History: 2015 to 2026

Beijing Strong Biotechnologies Inc's market capitalization history from 2015 to 2026. Data shows change from $1.86 Billion to $967.77 Million (-3.97% CAGR). Also see Beijing Strong Biotechnologies Inc cash flow conversion for how efficiently the company converts equity into cash flow.

Beijing Strong Biotechnologies Inc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Beijing Strong Biotechnologies Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Beijing Strong Biotechnologies Inc (300406) stock price for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.69x

Beijing Strong Biotechnologies Inc's market cap is 0.69 times its annual revenue

Industry average: 0.64x Higher than industry average

Latest Price to Earnings (P/E) Ratio

2.15x

Beijing Strong Biotechnologies Inc's market cap is 2.15 times its annual earnings

Industry average: 2.32x Lower than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2015 $1.86 Billion $566.20 Million $245.04 Million 3.29x 7.61x
2016 $1.76 Billion $667.40 Million $271.65 Million 2.64x 6.48x
2017 $1.22 Billion $694.28 Million $273.15 Million 1.76x 4.48x
2018 $807.68 Million $774.18 Million $300.67 Million 1.04x 2.69x
2019 $1.35 Billion $840.86 Million $331.65 Million 1.60x 4.07x
2020 $2.09 Billion $848.12 Million $112.28 Million 2.47x 18.62x
2021 $1.66 Billion $1.60 Billion $405.65 Million 1.04x 4.10x
2022 $1.38 Billion $1.51 Billion $389.10 Million 0.92x 3.56x
2023 $1.62 Billion $1.74 Billion $523.74 Million 0.93x 3.10x
2024 $1.15 Billion $1.66 Billion $532.64 Million 0.69x 2.15x

Competitor Companies of 300406 by Market Capitalization

Companies near Beijing Strong Biotechnologies Inc in the global market cap rankings as of September 19, 2026. Review 300406 tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Beijing Strong Biotechnologies Inc by market ranking:

  • Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #89 globally with a market cap of $224.59 Billion USD.
  • Danaher Corporation (NYSE:DHR): Ranked #160 globally with a market cap of $150.10 Billion USD.
  • WuXi AppTec Co Ltd (SHG:603259): Ranked #470 globally with a market cap of $58.08 Billion USD ( CN¥396.94 Billion CNY).
  • Natera Inc (NASDAQ:NTRA): Ranked #577 globally with a market cap of $47.01 Billion USD.
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#89 Thermo Fisher Scientific Inc NYSE:TMO $224.59 Billion $658.32
#160 Danaher Corporation NYSE:DHR $150.10 Billion $212.50
#470 WuXi AppTec Co Ltd SHG:603259 $58.08 Billion CN¥160.49
#577 Natera Inc NASDAQ:NTRA $47.01 Billion $366.31

Beijing Strong Biotechnologies Inc Historical Marketcap From 2015 to 2026

Between 2015 and today, Beijing Strong Biotechnologies Inc's market cap moved from $1.86 Billion to $ 967.77 Million, with a yearly change of -3.97%.

Year Market Cap Change (%)
2026 CN¥967.77 Million -13.70%
2025 CN¥1.12 Billion -2.17%
2024 CN¥1.15 Billion -29.30%
2023 CN¥1.62 Billion +17.19%
2022 CN¥1.38 Billion -16.90%
2021 CN¥1.66 Billion -20.38%
2020 CN¥2.09 Billion +55.09%
2019 CN¥1.35 Billion +66.93%
2018 CN¥807.68 Million -33.93%
2017 CN¥1.22 Billion -30.58%
2016 CN¥1.76 Billion -5.52%
2015 CN¥1.86 Billion --

End of Day Market Cap According to Different Sources

On Sep 18th, 2026 the market cap of Beijing Strong Biotechnologies Inc was reported to be:

Source Market Cap
Yahoo Finance $967.77 Million USD
MoneyControl $967.77 Million USD
MarketWatch $967.77 Million USD
marketcap.company $967.77 Million USD
Reuters $967.77 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Beijing Strong Biotechnologies Inc

SHE:300406 China Diagnostics & Research
Market Cap
$967.77 Million
CN¥6.61 Billion CNY
Market Cap Rank
#9080 Global
#2232 in China
Share Price
CN¥11.28
Change (1 day)
+0.89%
52-Week Range
CN¥10.82 - CN¥15.23
All Time High
CN¥24.76
About

Beijing Strong Biotechnologies,Inc. researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally. The company offers biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activ… Read more